Advyzon Investment Management LLC Acquires New Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Advyzon Investment Management LLC acquired a new stake in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund acquired 1,965 shares of the healthcare conglomerate's stock, valued at approximately $994,000.

Several other hedge funds have also modified their holdings of UNH. M&T Bank Corp boosted its holdings in UnitedHealth Group by 13.4% during the third quarter. M&T Bank Corp now owns 220,590 shares of the healthcare conglomerate's stock worth $128,975,000 after buying an additional 26,074 shares in the last quarter. Sugarloaf Wealth Management LLC grew its holdings in shares of UnitedHealth Group by 17.6% in the 4th quarter. Sugarloaf Wealth Management LLC now owns 7,957 shares of the healthcare conglomerate's stock worth $4,025,000 after acquiring an additional 1,193 shares during the period. Benjamin Edwards Inc. boosted its position in UnitedHealth Group by 1,275.3% during the third quarter. Benjamin Edwards Inc. now owns 44,547 shares of the healthcare conglomerate's stock worth $26,060,000 after purchasing an additional 41,308 shares in the last quarter. Parsifal Capital Management LP acquired a new position in shares of UnitedHealth Group during the 3rd quarter worth $21,165,000. Finally, Signal Advisors Wealth LLC grew its stake in UnitedHealth Group by 13.0% in the 4th quarter. Signal Advisors Wealth LLC now owns 9,115 shares of the healthcare conglomerate's stock valued at $4,611,000 after acquiring an additional 1,051 shares during the last quarter. 87.86% of the stock is owned by institutional investors and hedge funds.

UnitedHealth Group Stock Down 7.3 %

Shares of NYSE:UNH traded down $36.84 during midday trading on Friday, reaching $465.58. The company had a trading volume of 18,300,797 shares, compared to its average volume of 4,729,468. The stock has a market capitalization of $428.46 billion, a P/E ratio of 30.04, a PEG ratio of 1.40 and a beta of 0.61. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. UnitedHealth Group Incorporated has a one year low of $436.38 and a one year high of $630.73. The stock's fifty day moving average price is $520.37 and its 200-day moving average price is $561.26.

UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, beating the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The firm had revenue of $100.81 billion for the quarter, compared to analysts' expectations of $101.60 billion. During the same quarter in the prior year, the firm posted $5.83 earnings per share. UnitedHealth Group's revenue for the quarter was up 6.8% compared to the same quarter last year. Equities research analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

Insiders Place Their Bets

In related news, Director Timothy Patrick Flynn acquired 1,000 shares of UnitedHealth Group stock in a transaction that occurred on Friday, January 17th. The stock was acquired at an average price of $511.57 per share, for a total transaction of $511,570.00. Following the transaction, the director now directly owns 4,500 shares of the company's stock, valued at $2,302,065. This trade represents a 28.57 % increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. 0.33% of the stock is owned by corporate insiders.

Analyst Upgrades and Downgrades

A number of brokerages have commented on UNH. Oppenheimer increased their target price on UnitedHealth Group from $610.00 to $640.00 and gave the company an "outperform" rating in a report on Friday, December 6th. Deutsche Bank Aktiengesellschaft upped their target price on shares of UnitedHealth Group from $595.00 to $625.00 and gave the company a "buy" rating in a report on Tuesday, December 3rd. Wells Fargo & Company decreased their target price on shares of UnitedHealth Group from $694.00 to $660.00 and set an "overweight" rating on the stock in a research report on Tuesday, January 28th. KeyCorp reaffirmed an "overweight" rating and issued a $650.00 price objective on shares of UnitedHealth Group in a research report on Friday, January 17th. Finally, Stephens lifted their price target on shares of UnitedHealth Group from $605.00 to $675.00 and gave the company an "overweight" rating in a report on Thursday, December 5th. One investment analyst has rated the stock with a hold rating, twenty have assigned a buy rating and two have assigned a strong buy rating to the stock. Based on data from MarketBeat.com, UnitedHealth Group has a consensus rating of "Buy" and an average price target of $629.32.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.